Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

Add To Watchlist

Bullboard (TSXV:HEM)

View:

Post by Jon9800on Jun 23, 2022 11:47am

Hemostemix Announces the Incorporation of PreCerv Inc.

$HEM has announced it has incorporated PreCerv Inc. as a wholly owned subsidiary. PreCerv will obtain a license to NCP-01 and its autologous stem cell technologies.

109

Post by ENEMENEMYNEMOon Jun 23, 2022 8:43am

PP

PP closed... less money earned but maybe less needed!!! and less dilution. WalterTheDawg Has a PM.

105

Discover Options Trading Strategies to Minimize your Tax Burden

posted Dec 01, 2024 9:00am by Bank of Montreal

Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more

Post by zames007on Jun 23, 2022 7:52am

$HEM announced the addition of a wholly owned subsidiary

Hemostemix recently announced the incorporation of PreCerv Inc. (A wholly owned subsidiary of Hemostemix). Hemostemix will grant PreCerv a global field of use licence for NCP-01 and its autologous ...more

141

Post by Jon9800on Jun 23, 2022 7:19am

Hemostemix reclaims possession of all its lost intellectual

All the intellectual data including all phase 2 clinical trial data, all the historical data from hemostemix Israel, and the randomized table required to analyze North-American and South-African ACP ...more

165

Post by Jon9800on Jun 23, 2022 6:57am

Hemostemix regains legal possession of all its missing intel

140

(0)
•••

Post by PressReleaseon Jun 22, 2022 4:03pm

New Press Release - Hemostemix Announces Closing of UNIT Private Placement

Calgary, Alberta--(Newsfile Corp. - June 22, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it closed the first tranche of its non-brokered private placement of units ("Units") announced on May 19, 2022, for gross proceeds of $690,388.80 ...read article.

Post by trade007on Jun 22, 2022 3:25pm

Hemostemix to reimburse the finder’s fees

Hemostemix had planned to pay the finder’s fees of 8% by using the gross proceeds in connection with the current filing, clinical trial costs, regulatory fees, etc. with the balance to be used for ...more

151

Post by trade007on Jun 22, 2022 3:09pm

Data audit efficiently performed, results came out to be aut

Hemostemix have been handed back its intellectual property consisting of all the clinical trial data of ACP-01 which was long unlawfully held by Accudata and Aspire Health Science, the data audit post ...more

143

Post by robert345on Jun 22, 2022 2:25pm

$HEM regains legal custody of its lost intellectual property

The company has legally retrieved all intellectual data related to stage 2 clinical trial data, along with all previous data from Hemostemix Israel and the randomized table needed to evaluate ACP-01 ...more

154

Post by robert345on Jun 22, 2022 2:22pm

$HEM expansion of the common share and warrant the offer

The recently announced private placement of 15 million units, in which each full unit consists of one common share and one purchase warrant, each full warrant entitles the holder to acquire one common ...more

155

Post by Jon9800on Jun 22, 2022 11:52am

$HMTXF rendering investors staggered with profit on the OTC

HMTXF today marked a rather gallant opening on the OTC market, and is currently trading at 0.2035 with an up-hill progression in the market.

115

Post by Jon9800on Jun 22, 2022 11:09am

Treating efficiency of NCP-01 a revolutionary invention by H

Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem cell technology, which can treat disorders of the central and peripheral nervous systems. Spinal cord injury, chronic ...more

127

Post by Jon9800on Jun 22, 2022 9:52am

Hemostemix – company outlook & stock Insights

Hemostemix Inc. (TSX-V: $HEM) is a publicly-traded biotech company. Its principal business is developing, manufacturing, and commercializing innovative blood-derived stem cell therapies. The company ...more

130

Post by Jon9800on Jun 22, 2022 9:46am

Hemostemix medication plan for cardiac arrest

The company, one of the leading products, ACPs delivered via injection engrafted into the damaged or dying cardiac tissue, improved the normal functioning.

Post by Jon9800on Jun 22, 2022 6:48am

The participation of Officer in the offering by TSX-V

The participation of an Officer in the offering constitutes a related transaction within the meaning of multilateral instrument 61-101 – Protection of Minority Security Holders in Special Transactions ...more

163

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSXV:HEM)